Similar Posts
Feinberg on TARP & Executive Compensation
Kenneth R. Feinberg, former Special Master for TARP Executive Compensation (June 2009 – September 2010), testifies to Congressional Oversight panel on executive compensation restrictions for companies that received Troubled Asset Relief Program (TARP) funds.
Double-Dip Fears Unlikely to Fade
“Concerns over a ‘double-dip’ recession seem overdone, but fears are unlikely to fade as economic tensions linger,” Ashok Shah, the Chief Investment Officer at London & Capital, told CNBC Wednesday.
Crescenzi's Final Thoughts
Concluding thoughts on the market and economy, with Tony Crescenzi, PIMCO.
Going for Gold- Barrick Gold CEO Aaron Regent
Toronto-based minder Barrick Gold posting better-than-expected earnings, with Aaron Regent, Barrick Gold CEO.
Study Identifies Heart Risks in Glaxo's Avandia
Study Identifies Heart Risks in Glaxo’s Avandia. Dr. Steven Nissen, of the Cleveland Clinic, authored a controversial study identifying heart risks in GlaxoSmithKline’s Avandia diabetes drug. He talks to CNBC’s Mike Huckman.
European Stress Tests
Global investors are waiting for the results of the stress tests on European banks, with CNBC’s Silvia Wadhwa.